Paul A Mahon United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,710 shares of UTHR, which is worth approximately $13.7 Million. The most recent transaction as insider was on Mar 04, 2021, when has been sold 6,000 shares (Common Stock) at a price of $160.34 per share, resulting in proceeds of $962,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
0% 3M change
0.3% 12M change
Total Value Held $13.7 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
SELL
Sale (or disposition) back to the issuer
$962,040 $160.34 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Mar 04 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Feb 18 2021
SELL
Sale (or disposition) back to the issuer
$1,015,980 $169.33 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Feb 04 2021
SELL
Sale (or disposition) back to the issuer
$1,006,980 $167.83 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Feb 04 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Jan 21 2021
SELL
Sale (or disposition) back to the issuer
$1,002,840 $167.14 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Jan 21 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Jan 07 2021
SELL
Sale (or disposition) back to the issuer
$1,002,300 $167.05 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Dec 17 2020
SELL
Sale (or disposition) back to the issuer
$890,640 $148.44 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Dec 17 2020
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Dec 03 2020
SELL
Sale (or disposition) back to the issuer
$779,640 $129.94 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
Nov 05 2020
SELL
Sale (or disposition) back to the issuer
$826,260 $137.71 p/Share
6,000 Reduced 14.24%
36,131 Common Stock
Nov 05 2020
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.47%
42,131 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR